Clinical value of precise staging for pancreatic carcinoma
10.3760/cma.j.issn.1007-8118.2018.02.021
- VernacularTitle:胰腺癌的精准分期及临床价值
- Author:
Xiangyu QIU
1
;
Jianwei GAO
;
Xinbo WANG
Author Information
1. 210002,南京大学医学院附属金陵医院解放军南京总医院普通外科
- Keywords:
Pancreatic carcinoma,staging;
Borderline resectability status;
GTNMLVP stage;
Standardized pancreatic surgery classification;
Genetics classification
- From:
Chinese Journal of Hepatobiliary Surgery
2018;24(2):139-144
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic carcinoma remains one of the most challenging malignant tumor with an increasing morbidity in China.The significance of multidisciplinary and comprehensive treatment of pancreatic cancer has been recognized in recent years.Moreover,several novel clinical staging standards of pancreatic cancer have emerged to help optimize the treatment strategies and improve patients' prognosis in precise treatment era.Currently,in addition to the traditional TNM stage,usage of histologic grade (G),resection marginstatus (M),lymphatic invasion status (L),vascular invasion status (V),perineurial invasion status (P) and combination of these stages recommended by NCCN guideline as GTNMLVP stage have emerged.Other novel staging standards include respectability status,standardized pancreatic surgery classification,genetics classification,etc.This review summarized the characteristics and clinical significance of these novel established methods for pancreatic cancer precise staging.
